We'll have the cash, for sure imo.....else we would have heard by now? As to our longterm partner/buyer its OCD who could buy us out from the petty cash drawer. Just wish they would get on with it! We might do a bond raise a la Gnl for £10m? But more likely we are being readied for sale to OCD as you and Del have said "its just a question of price"and what would be acceptable to the iis? They will have to take quite a haircut so sub 90p and above 40p................ might 70p appeal?Thats only mrk cap of £40m and considering we have spent that and more to this point might not appeal? Outside of a sale at an agreed price its back to going it alone with some form of new funding. Prefer option no 2 unless we can get north of 70p. The bod with no skin in the game would vote for independence and a continuance of steady employment. Wont be long.
Yes JL, they seem no more than a long shot punt to me. Usually avoid UK Medtech but saw presentation on Sphere a few years ago and was impressed looked Iike it had great potential. Still think it does although original cast/founder has changed but as with other UK medtech needs lots of cash and a global partner to realise product potential. Let's see.....
Its a blessed relief!!!
The relative peace and quite of this board...LOL.. 0 trades......Ahhhhhhhhhhhhhhh.....:-)
Any one of those 4 options should see the sp lower! Im having a bad day on Gnl bb must not let the effin shennanigans over there colour my view on Sphere! I trust WB999 you have stayed clear of o....lies?
Agreed, results must be timed to be coincident with funding news and distribution deal, MBO or sale, seem to be the only possibilities.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.